18
Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD, MS Stephen L. Priori and the Editorial Board of ISPOR CONNECTIONS This is a joint project of ISPOR CONNECTIONS and the Health Care Decisions Using Outcomes Research SIG The aim of this project is to bridge the understanding between pharmacoeconomics & outcomes researchers and decision makers

Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Embed Size (px)

Citation preview

Page 1: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Use of Pharmacoeconomics & Outcomes Research

Information in Health Care Decisions – SURVEY Results

Peter K Wong, PhD, MS, MBA, RPhSteve Marx, PharmD, MS

Stephen L. Priori and the Editorial Board of ISPOR CONNECTIONS

This is a joint project of ISPOR CONNECTIONS and the Health Care Decisions Using Outcomes Research SIG

The aim of this project is to bridge the understanding between pharmacoeconomics & outcomes researchers

and decision makers

Page 2: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #1 Do you consider

yourself a drug, medical device or diagnostic treatment decision maker?

Yes-34.43% No-65.57% 42 out 122

responded with Yes For the rest of the

survey, N is equal to 42

0%

10%

20%

30%

40%

50%

60%

70%

Yes No

Page 3: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #2

How long have you been a decision maker?

0%

5%

10%

15%

20%

25%

30%

35%

40%

Lessthan 1year

1-5 years 6-10years

11-15years

16-20years

> 20years

Page 4: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #3What is your

current occupation?

0% 5% 10% 15% 20% 25% 30%

Health Care Administrator-Health Plan

Health Care Decision Maker-Government

Health Care Administrator-Hospital

Practicing Physician

Practicing Pharmacist

Pharmacy and Therapeutic Committee Member

Technology Assessment Committee Member

Other

Page 5: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #4 In which country do you

reside?

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

USA

Canad

a

United

King

dom

Germ

any

China

Japa

n

Franc

e

Austra

liaOth

er

Page 6: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #5Please describe your residing

country's health care financing method(s).

0%10%20%30%40%50%60%70%

Page 7: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #6 In your residing country, who has the authority to

make drug, medical device, or diagnostics treatment reimbursement decisions that will impact

patient care?

0% 10% 20% 30% 40% 50% 60% 70% 80%

National Government

Regional Government

National Insurance Health Plan

Regional Insurance Health Plan

Pharmacy and Therapeutic Committee

Direct Care Providers

Patients

Other

Page 8: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #7Please indicate if your employer has any of these

committees whose function is to assess and select drug, medical device, or diagnostics treatments at a national,

regional or local level?

0% 10% 20% 30% 40% 50% 60% 70% 80%

Pharmacy andTherapeuticCommittee

TechnologyAssessmentCommittee

Other

Page 9: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #8Referring to the last question, on which

committee are you a member?

0%5%

10%15%20%25%30%35%40%45%50%

Other None Pharmacy andTherapeuticCommittee

TechnologyAssessmentCommittee

Page 10: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #9Have you read any articles that have

used any of these terms?

40%50%60%70%80%90%

100%

Page 11: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #10Do you have any training in the areas listed below? (The term training in this survey refers to as 'formal schooling,

attended courses, worked with an expert, or read extensively)

95% Answered Yes

20%30%40%50%60%70%80%90%

100%

Page 12: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #11 Referring to the

last question, in your opinion, did the training help you in your decisions in selecting the appropriate drug, medical device or diagnostics treatment?

Note: Two did not respond at all

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Yes No No Opinion

Page 13: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #12Which types of analysis have you used to make health decisions?

0%10%20%30%40%50%60%70%80%

•86% responded with Yes

Page 14: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #13Have you conducted or participated in any

studies using these pharmacoeconomics and outcomes research methods?

0%10%20%30%40%50%60%70%

Cost-B

enef

it Ana

lysis

Cost-U

tility

Analys

is

Burde

n of

Illne

ss

Quality

Adju

sted

Life.

..

Cost M

inim

izatio

n An.

..

Cost-E

ffecti

vene

ss A

...

Cost-o

f-Illn

ess

Health

Rela

ted

Quali..

•79% responded Yes

Page 15: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #14

In your last drug, medical device or diagnostics treatment decision, was pharmaco-economics and/or outcomes research information considered? 0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

Yes No No opinion

Page 16: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #15

Do you routinely use the pharmaco-economics and outcomes research information to make drug, medical device, or diagnostic treatment decisions?

0%

10%

20%

30%

40%

50%

60%

70%

80%

Yes No

Page 17: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #16In your opinion, which method(s) provide you with the best information to make your drug,

medical device, or diagnostic treatment decisions

0%10%20%30%40%50%60%70%

Page 18: Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Question #17 As a decision maker, do you feel you have been provided

with adequate pharmacoeconomics and outcomes research information to make drug, medical device, or

diagnostics treatment decisions?

0%5%

10%15%20%25%30%35%40%45%50%

Totally inadequate Somewhatinadequate

Adequateinformation

Too muchinformation